Correction. In the article "Human Phosphoribosylpyrophosphate Synthetase: Increased Enzyme Specific Activity in a Family with Gout and Excessive Purine Synthesis," by Becker, M. A., Kostel, P. J., Meyer, L. J. & Seegmiller, J. E., which appeared in the October 1973 issue of the Proc. Nat. Acad. Sci. USA 70, 2749-2752, Fig. 1 , p. 2750, was reproduced improperly by the printer. The figure and its accompanying legend are reprinted here. The investigation described in the article, was supported by grants AM 05646, AM 13622, and GM 17702 from the National Institutes of Health.
FIG. 1.
Immunoprecipitation analysis of the reaction between purified human erythrocyte PP-ribose-P synthetase and rabbit serum. Center well contained 25 Al of 5000-fold purified normal PP-ribose-P synthetase (460 Mg/ml). Numbered wells contained the following: wells 1 and 6, serum from immunized rabbits; wells 2 and 5, serum from unimmunized rabbits; wells 3 and 4, IgG fractions from unimmunized and immunized rabbits, respectively. Double diffusion was done for 24 hr at 4°. Single precipitin bands are noted only where outer wells contained immunoglobulin from rabbits immunized with the purified enzyme.
Correction. In the article "Neutron Diffraction Structure of Melampodin: Its Role in the Reclassification of the Germacranolides," by Watkins, S. F., Fischer, N. H. & Bernal, I., which appeared in the August 1973 issue of Proc. Nat. Acad. Sci. USA 70, 2434-2438, the footnote at the bottom of page 2437 should be deleted.
Correction. In the article "Nucleotide Modification In Vitro of the Precursor of Transfer RNATYr of Escherichia coli," by Schaefer, K. P., Altman, S., and S611, D., which appeared in Part I of the December 1973 issue of Proc. Nat. Acad. Sci. USA 70, 3626-3630, the following correction should be made. On p. 3628, the top line of the second column should read,"... found next to the anticodon (U40). In mature tRNA (18) Mouse teratocarcinomas arise from abnormally proliferating primordial germ cells in male embryos (1) . Some can be serially transplanted either subcutaneously or intraperitoneally. In the latter case, tumor-bearing mice exhibit ascites-containing "embryoid bodies" which resemble normal morulae and blastulae in morphology and potential for differentiation. When grown in culture, embryoid bodies give rise not only to primitive teratocarcinoma (PTC) cells, but also to various differentiated cell types (DTC). From PTC cells, lines can be established in culture that remain "undifferentiated." Some of these, when injected into mice, give rise to tumors containing various tissues (2, 3) . Such a system should provide valuable material for studying differentiation, provided PTC cells in culture can be shown to share some properties with early embryo cells.
We Tumor Lines. The tumor we received from Dr. B. Ephrussi originated from tumor OTT6050 of Stevens (4) . It was maintained by serial transfer into 129/Sv-CP (129) mice.
One derivative resembled the yolk-sac carcinomas described by Pierce (5) .
Cell Lines. Several lines were derived from embryoid bodies of tumor OTT6050. They are listed in Table 1 , together with other teratoma cells used. We took as PTC prototype F9, isolated by Mrs. Grandchamp in Dr. Ephrussi's laboratory. In vivo, some cell lines (such as PCC3 and PCC4) retain the capacity to form derivatives of all three germ layers. Others have partially (such as PTE) or totally (such as F9 or T17) lost that capacity. Nonteratoma cell lines are listed in Table 2 .
Cell Cultures. F9 and G26 cells were cultivated in tissueculture dishes coated with gelatin in Dulbecco's modified Eagle's medium containing 15% fetal-calf serum in an atmosphere of 12% CO2. The other cell lines used do not require gelatin. All cells were free of pleuropneumonia-like organisms (PPLO) except F9, which contained rat-type PPLO. Subsequently, a PPLO-free derivative of F9, reisolated by passage of the cells in mice, was found to behave exactly as the original line.
Antisera. We prepared antisera against PTC by hyperimmunizing 129 male mice every 2 weeks (Table 3) Absorptions were performed at 40 for 30 min with 1 volume of C': 2 volumes of cells to diluted serum. The dilution of antisera selected for absorption was about two doubling dilutions below the titer.
Preimplantation Embryos. (a) For peroxidase test. Virgin female mice, 6-7 weeks old, were injected with 4 IU of pregnant mare serum (Endopancrine-Paris) and 44 hr later with 5 IU of human chorionic gonadotropin (Ayerst Laboratory, New York). They were then penned with males of the same strain. Preimplantation embryos were flushed from the fallopian tubes at various intervals after detection of a copulation plug. They were washed and the zona pellucida was removed with Pronase (7). Embryos were incubated for 2 hr at 370 under 5% CO2. They fixed with glutaraldehyde, were incubated in 0.01 ml of diluted anti-F9 or in preimmunization serum for 20 hr at 4°. They were washed three times in Eagle's medium and transferred into 0.01 ml of Eagle's medium containing 4% IPT and 125 jug/ml of purified antibodies against mouse immunoglobulins prepared in sheep coupled with peroxidase (9).
After 3 hr at 40, the cells were washed three times in Eagle's medium and once in distilled water. They were transferred into 0.005 ml of 0.05 M acetate buffer (pH 5.0). Then 0.005 Teratoma Antigens Crossreacting with Early Embryos ml of a reaction mixture [2 mg of 3-amino-9-ethyl carbazole in 10 ml of acetate buffer (pH 5.0) (10) and a drop of a 3% solution of hydrogen peroxide] was added. The reaction was stopped after 30 min by replacing the medium with distilled water.
RESULTS
Activity of Syngeneic 129 Male Antiserum Against PTC (F9) cells. After five immunizations, immune sera were extremely active in the cytotoxicity test on F9, with a prozone below 1: 20, 95% killed, and titers in the range of 1: 3000 (Fig. 1) . These results were confirmed by the indirect peroxidase test. At serum dilutions between 1:100 and 1: 3200, F9 cells were stained when treated with the immune serum but not with preimmunization serum. At serum dilutions lower than 1:100, nonspecific staining can be observed with the control serum.
Activity of Antiserum Against F9 Cells Against Other Teratoma Cells. By cytotoxicity test, antisera against F9 reacted with PTC but not with DTC cell lines, even though in some cases both were isolated from the same tumor. In addition to F9, three other independently isolated PTC lines were tested. T17 (2) , which currently does not differentiate in vivo (J. Jami, personal communication), was susceptible to cytotoxic lysis to the same degree as F9. PCC3 and PCC4, two PTC lines isolated from OTT6050 in this laboratory by Dr. H. Jakob, are homogeneous in culture when maintained in exponential growth, the conditions under which they are tested. Unlike F9 and T17, these two lines give rise to derivatives of all three germ layers when injected into mice. Even at low dilutions, antiserum against F9 did not kill more than 40 and 60% of PCC3 and PCC4 cells, respectively. PCC4 cells, however, removed all activity against F9 by absorption (Fig. 2) .
The activity of antiserum against F9 was also assayed by cytotoxicity tests against a series of differentiated cells: PCD1, PCD2, PTE, and neural cells from PCC3, all derived from the same original tumor (OTT6050). In addition, neural cells cultured from LS 4799.508 were also negative (see Table  1 ). In no case was any reaction detected, either by cytotoxicity or by comparative absorption tests (Fig. 2) .
Activity of Antisera Against F9 Cells Against Nonteratoma Cells. Antiserum against F9 was assayed by cytotoxicity tests against several cells of various origins, some of which carry defined viral cell-surface antigens ( (12) . Direct immunological approach with early-embryo cells for immunization is hindered by the scarcity of material, hence the interest of the mouse teratocarcinoma system from which various primitive and differentiated cell lines can be isolated and provided in quantity.
There has already been one report concerning immunological crossreaction between teratoma and embryo cells (13) . These results, however, are difficult to interpret because (1) embryoid bodies-i.e., a mixture of cell types-were used as the immunogen and (2) sera prepared in rabbits can contain, even after absorption, antibodies against mice that are not specific for teratomas and eggs.
The studies described here show that PTC (F9) cells from culture elicit, in syngeneic male mice, formation of specific antibodies that react with the surface of all other PTC cell lines tested but not of differentiated cells that originate from the same tumor. This absence of crossreaction with cells of comparable origin underlines the specificity of the reaction. All these PTC cell lines have, therefore, in common some specific surface antigen(s). This hypothesis has been confirmed by the production in syngeneic mice of a serum against another PTC line (PCC4), a serum that lyses 95% of F9 cells but only 50% of PCC3 and PCC4. It is not possible to say whether this is an effect on antigen masking nor whether this effect is related to the capacity of these latter lines to differentiate.
The number of antigens observed here is unknown. PTC cells are highly tumorigenic, and some tumor antigens might be present on their cell surfaces. No crossreaction, however, has been observed with various viral tumor antigens. Antibodies against PTC do not react with any differentiated cell type derived from the same teratoma or from other teratomas or from adult mice, except male germ cells from different mouse strains. The latter reaction suggests the presence of at least two types of antibodies in antisera against F9 because (1) after absorption with testis cells, sera retain some anti-F9 activity and (2) the slope of the titration curve is much less steep than usually observed when one antigen is involved.
The most significant result reported here is the reaction of antisera against PTC with mouse morula cells. The reaction appears to increase from very little, if any, with 1-cell eggs to a maximum at the 8-cell stage. This result suggests the progressive expression of a new surface antigen(s) during the earliest stages of development. For such a component(s) to become immunogenic in a syngeneic organism, it has to disappear early from the embryo. This is precisely what can be expected of a surface antigen playing a role at an early stage of development.
